Ying Chieh Han

Mr. Ying Chieh Han


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
YHYing Chieh Han
Ying Chieh Han
KLKatarina Laketic
Katarina Laketic
KHKylie K. Hornaday
Kylie K. Hornaday
DONNA M SLATERDONNA M SLATER
DONNA M SLATER
CMChunlong Mu
Chunlong Mu
Jane ShearerJane Shearer
Jane Shearer
Preterm birth, defined as any birth before 37 weeks of completed gestation, poses adverse health risks to both mothers and infants. Despite preterm birth being associated with several risk factors, its relationship to maternal metabolism remains unclear, especially in first-time mothers. Aims of the present study were to identify maternal metabolic disruptions associated with preterm birth and to evaluate their predictive potentials. Blood was collected, and the serum harvested from the mothers of 24 preterm and 42 term births at 28–32 weeks gestation (onset of the 3rd trimester). Serum samples were assayed by untargeted metabolomic analyses via liquid chromatography/mass spectrometry (QTOF-LC/MS). Metabolites were annotated by inputting the observed mass-to-charge ratio into the Human Metabolome Database (HMDB). Analysis of 181 identified metabolites by PLS-DA modeling using SIMCA (v17) showed reasonable separation between the two groups (CV-ANOVA, p = 0.02). Further statistical analysis revealed lower serum levels of various acyl carnitines and amino acid metabolites in preterm mothers. Butenylcarnitine (C4:1), a short-chain acylcarnitine, was found to be the most predictive of preterm birth (AUROC = 0.73, [CI] 0.60–0.86). These observations, in conjuncture with past literature, reveal disruptions in fatty acid oxidation and energy metabolism in preterm primigravida. While these findings require validation, they reflect altered metabolic pathways that may be predictive of preterm delivery in primigravida.

1 January 2025 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
YHYing Chieh Han
Ying Chieh Han
JSJane Shearer
Jane Shearer
CMChunlong Mu
Chunlong Mu
DSDonna M. Slater
Donna M. Slater
STSuzanne C. Tough
Suzanne C. Tough
GDGavin E. Duggan
Gavin E. Duggan
Background: Machine learning (ML), with advancements in algorithms and computations, is seeing an increased presence in life science research. This study investigated several ML models' efficacy in predicting preterm birth using untargeted metabolomics from serum collected during the third trimester of gestation. Methods: Samples from 48 preterm and 102 term delivery mothers from the All Our Families Cohort (Calgary, AB) were examined. Four ML algorithms: Partial Least Squares Discriminant Analysis (PLS-DA), linear logistic regression, artificial neural networks (ANN), Extreme Gradient Boosting (XGBoost) - with and without bootstrap resampling were used to examine the small-scale clinical dataset for both model performance and metabolite interpretation. Results: Model performance was evaluated based on confusion matrices, area under the receiver operating characteristic (AUROC) curve analysis, and feature importance rankings. Linear models such as PLS-DA and logistic regression demonstrated moderate classification performance (AUROC ≈ 0.60), whereas non-linear approaches, including ANN and XGBoost, exhibited marginal improvements. Among all models, XGBoost combined with bootstrap resampling achieved the highest performance, yielding an AUROC of 0.85 (95 % CI: 0.57–0.99, p < 0.001), indicating a significant improvement in classification accuracy. Metabolite importance, derived from Shapley Additive Explanations (SHAP), consistently identified acylcarnitines and amino acid derivatives as principal discriminative features. Pathway analysis revealed disruptions to tyrosine metabolism as well as phenylalanine, tyrosine and tryptophan biosynthesis to be associated with preterm delivery. Conclusions: Our results highlight the complexity of metabolomics-based modelling for preterm birth and support an iterative, model-driven approach for optimizing predictive accuracy in small-scale clinical datasets.